Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis.
Mol Genet Metab Rep
; 21: 100513, 2019 Dec.
Article
em En
| MEDLINE
| ID: mdl-31534909
4MU, 4-methylumbelliferyl; AAV, adeno-associated virus; AAV9, AAV serotype 9; BSA, bovine serum albumin; CNS, central nervous system; CPB, citrate phosphate buffer; EB, embryoid body; GFP, green fluorescent protein; HPTLC, high-performance thin-layer chromatography; PBS, phosphate-buffered saline; RT-qPCR, real-time quantitative polymerase chain reaction; SD, standard deviation; X-gal, 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside; hiPSC, human induced pluripotent stem cells; iPS, induced pluripotent stem; ß-gal, ß-galactosidase
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article